WO2019234677A3 - Biomarqueurs pour un diagnostic précoce non invasif de maladies infectieuses - Google Patents
Biomarqueurs pour un diagnostic précoce non invasif de maladies infectieuses Download PDFInfo
- Publication number
- WO2019234677A3 WO2019234677A3 PCT/IB2019/054716 IB2019054716W WO2019234677A3 WO 2019234677 A3 WO2019234677 A3 WO 2019234677A3 IB 2019054716 W IB2019054716 W IB 2019054716W WO 2019234677 A3 WO2019234677 A3 WO 2019234677A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- biomarkers
- early diagnosis
- infectious diseases
- invasive early
- subject
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4713—Plasma globulins, lactoglobulin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7095—Inflammation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
La présente invention concerne une méthode de diagnostic précoce non invasif de maladies infectieuses, en particulier la mammite, chez un sujet, par la détermination, dans un échantillon de liquide biologique, en particulier du liquide lacrymal, en provenance dudit sujet, de la quantité d'au moins deux biomarqueurs choisis parmi un panel, et la comparaison desdites quantités avec les valeurs de référence correspondantes. La variation combinée de la quantité de chacun desdits biomarqueurs par rapport à la valeur de référence correspondante indique l'apparition de la maladie infectieuse.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19736814.5A EP3803393A2 (fr) | 2018-06-08 | 2019-06-06 | Biomarqueurs pour un diagnostic précoce non invasif de maladies infectieuses |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102018000006170 | 2018-06-08 | ||
IT102018000006170A IT201800006170A1 (it) | 2018-06-08 | 2018-06-08 | Biomarcatori per la diagnosi precoce non invasiva di patologie infettive |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2019234677A2 WO2019234677A2 (fr) | 2019-12-12 |
WO2019234677A3 true WO2019234677A3 (fr) | 2020-03-12 |
Family
ID=63579612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2019/054716 WO2019234677A2 (fr) | 2018-06-08 | 2019-06-06 | Biomarqueurs pour un diagnostic précoce non invasif de maladies infectieuses |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3803393A2 (fr) |
IT (1) | IT201800006170A1 (fr) |
WO (1) | WO2019234677A2 (fr) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120045778A1 (en) * | 2010-08-23 | 2012-02-23 | The Ohio State University Research Foundation | Elisa for haptoglobin-matrix metalloproteinase 9 complex as a diagnostic test for conditions including acute inflammation |
WO2013014669A1 (fr) * | 2011-07-24 | 2013-01-31 | Carmel-Haifa University Economic Corp. | Fragments de lactoferrine et leur utilisation |
CA2988833A1 (fr) * | 2015-06-10 | 2016-12-15 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. | Procede et dispositif pour surveiller l'etat de sante de vaches laitieres |
-
2018
- 2018-06-08 IT IT102018000006170A patent/IT201800006170A1/it unknown
-
2019
- 2019-06-06 WO PCT/IB2019/054716 patent/WO2019234677A2/fr unknown
- 2019-06-06 EP EP19736814.5A patent/EP3803393A2/fr active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120045778A1 (en) * | 2010-08-23 | 2012-02-23 | The Ohio State University Research Foundation | Elisa for haptoglobin-matrix metalloproteinase 9 complex as a diagnostic test for conditions including acute inflammation |
WO2013014669A1 (fr) * | 2011-07-24 | 2013-01-31 | Carmel-Haifa University Economic Corp. | Fragments de lactoferrine et leur utilisation |
CA2988833A1 (fr) * | 2015-06-10 | 2016-12-15 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. | Procede et dispositif pour surveiller l'etat de sante de vaches laitieres |
Non-Patent Citations (6)
Title |
---|
BOEHMER J L ET AL: "Proteomic Analysis of Differentially Expressed Proteins in Bovine Milk During Experimentally Induced Escherichia coli Mastitis", JOURNAL OF DAIRY SCIENCE, AMERICAN DAIRY SCIENCE ASSOCIATION, US, vol. 91, no. 11, 1 November 2008 (2008-11-01), pages 4206 - 4218, XP026955103, ISSN: 0022-0302, [retrieved on 20081101] * |
CARLA DUARTE ET AL: "Technological advances in bovine mastitis diagnosis: an overview", JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, vol. 27, no. 6, 1 January 2015 (2015-01-01), pages 665 - 672, XP055450209 * |
CARLO DE OLIVEIRA MARTINS ET AL: "Distinct Mitral Valve Proteomic Profiles in Rheumatic Heart Disease and Myxomatous Degeneration", CLINICAL MEDICINE INSIGHTS: CARDIOLOGY, vol. 8, 1 January 2014 (2014-01-01), XP055524234, ISSN: 1179-5468, DOI: 10.4137/CMC.S17622 * |
JINMING HUANG ET AL: "iTRAQ-proteomics and bioinformatics analyses of mammary tissue from cows with clinical mastitis due to natural infection with Staphylococci aureus", BMC GENOMICS, BIOMED CENTRAL, vol. 15, no. 1, 2 October 2014 (2014-10-02), pages 839, XP021199100, ISSN: 1471-2164, DOI: 10.1186/1471-2164-15-839 * |
KALMUS P ET AL: "Milk haptoglobin, milk amyloid A, and N-acetyl-[beta]-D-glucosaminidase activity in bovines with naturally occurring clinical mastitis diagnosed with a quantitative PCR test", JOURNAL OF DAIRY SCIENCE, AMERICAN DAIRY SCIENCE ASSOCIATION, US, vol. 96, no. 6, 1 June 2013 (2013-06-01), pages 3662 - 3670, XP002759760, ISSN: 0022-0302, [retrieved on 20130330], DOI: 10.3168/JDS.2012-6177 * |
SHOAIB ASHRAF ET AL: "Clumping factor A of Staphylococcus aureus interacts with AnnexinA2 on mammary epithelial cells", SCIENTIFIC REPORTS, vol. 7, no. 1, 19 January 2017 (2017-01-19), XP055524226, DOI: 10.1038/srep40608 * |
Also Published As
Publication number | Publication date |
---|---|
WO2019234677A2 (fr) | 2019-12-12 |
EP3803393A2 (fr) | 2021-04-14 |
IT201800006170A1 (it) | 2019-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006127861A3 (fr) | Diagnostic de maladies et d'etats pathologiques par l'analyse d'echantillons biologiques traites par voie histopathologique a l'aide de preparations tissulaires liquides | |
EP2199306A3 (fr) | Anticorps humain spécifique VEGF | |
WO2019126556A3 (fr) | Test théragnostique pour le traitement antifongique de maladies inflammatoires | |
WO2015034886A3 (fr) | Panneau de bien-être pour animaux de compagnie | |
EP4299586A3 (fr) | Procédés et compositions pour la détection et le diagnostic d'une maladie rénale et d'une maladie parodontale | |
WO2015136509A3 (fr) | Cibles diagnostiques et thérapeutiques de la prééclampsie et d'autres complications étroitement associées à la grossesse | |
MX2019012439A (es) | Herramienta de diagnostico para determinar el borramiento del proceso del pie del podocito. | |
WO2019234677A3 (fr) | Biomarqueurs pour un diagnostic précoce non invasif de maladies infectieuses | |
ZA202201448B (en) | A biomarker for alzheimer's disease using blood samples from clinically diagnosed alzheimer's disease subjects | |
WO2020213969A3 (fr) | Biomarqueur pour diagnostiquer un dysfonctionnement des cellules endothéliales cornéennes | |
Güldoğan et al. | Correlation between ischemia-modified albumin and Ranson score in acute pancreatitis | |
JP2016502406A5 (fr) | ||
WO2017053718A3 (fr) | Biomarqueurs pour la détection précoce de la maladie de parkinson | |
RU2014113841A (ru) | Способ ранней диагностики эндогенной интоксикации | |
CA2984732C (fr) | Methode de diagnostic in vitro de la maladie d'alzheimer, fondee sur le taux de redox d'albumine dans le liquide cerebrospinal | |
WO2017204446A3 (fr) | Procédé d'analyse de l'activité de cellules tueuses naturelles à l'aide de l'activité synergique d'un récepteur, et procédé de diagnostic de maladie associée à l'activité des cellules tueuses naturelles utilisant ledit procédé d'analyse | |
Kwak et al. | Multiple biomarkers for molecular diagnosis of sarcopenia | |
RU2016117069A (ru) | Способ диагностики степени тяжести гиперандрогении | |
RU2019133312A (ru) | Способ ранней доклинической диагностики болезни Паркинсона по концентрации катехоламинов в слезной жидкости пациента | |
WO2015103664A8 (fr) | Classement du risque lié à la grippe | |
JP2015503106A5 (fr) | ||
WO2017059276A3 (fr) | Procédés thérapeutiques et diagnostiques pour des maladies autoimmunes et/ou des inflammations | |
WO2015158608A3 (fr) | Diagnostic d'une néphropathie chronique par analyse quantitative de modifications post-translationnelles des protéines plasmatiques | |
FR3100452B1 (fr) | Méthode de diagnostic de peaux agées | |
RU2006122690A (ru) | Способ диагностики герпесвирусных заболеваний глаз |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19736814 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2019736814 Country of ref document: EP Effective date: 20210111 |